Target intelligence / Profile preview

Zinc finger protein 804A (ZNF804A)

Target
ZNF804A
Molecular classification
Transcription factor, C2H2-type zinc finger protein, DNA-binding protein
01

Overview

Zinc finger protein 804A is a DNA-binding protein encoded by the ZNF804A gene on human chromosome 2q32.1. It contains a canonical C2H2-type zinc finger domain near its N-terminus, which enables it to interact with DNA and potentially regulate gene expression as a transcription factor[1][3][5]. ZNF804A is highly expressed in the brain, particularly during neurodevelopment, and is enriched in neurites and dendritic spines where it plays key roles in neuronal differentiation, migration, neurite outgrowth, and the regulation of synapse formation and dendritic spine maintenance[2][3][4]. Genome-wide association studies have robustly linked variation in this gene to schizophrenia, bipolar disorder, autism spectrum disorder, and related psychiatric and neurodevelopmental conditions, indicating its critical, dosage-sensitive role in brain development and function[2][3][4]. The detailed molecular mechanisms by which ZNF804A impacts disease risk include influencing the expression of other genes involved in dopaminergic neurotransmission (such as DRD2 and COMT) and cell adhesion; however, ZNF804A itself has not yet been established as a direct therapeutic target, and no drugs currently modulate its activity[2][3].

Other names
ZNF804AC2orf10zinc finger protein 804A
02

Mechanism of action

Not applicable; no drugs currently known to modulate ZNF804A directly.

03

Biological functions

Regulation of gene expression (likely through DNA binding)Neurodevelopment, including neurite outgrowth and dendritic spine formationRegulation of neuronal migration and synaptic plasticityModulation of cell adhesion gene expression
04

Disease associations

Neuropsychiatric disorders (especially schizophrenia, bipolar disorder, autism spectrum disorders, anxiety)Other (general neurodevelopmental pathologies)
05

Safety considerations

None established for drug targeting, as it is not currently a direct therapeutic target. Changes in ZNF804A expression levels are associated with neurodevelopmental and psychiatric disease risks
06

Interacting drugs

None identified in search results; no known approved drugs directly target ZNF804A.
07

Biomarkers

Certain SNPs in ZNF804A (notably rs7597593 and rs1344706) are associated with risk for schizophrenia and may be used as genetic biomarkers in research settings

Beyond the preview

Go deeper on Zinc finger protein 804A (ZNF804A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc finger protein 804A (ZNF804A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call